Trademarkia Logo

Canada

C$
UNAMITY
REGISTERED

on 2 Aug 2019

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1771260 filed on 8th Mar 2016

Registration Number

TMA1046555 registered on 2th Aug 2019

Registration expiry Date

2th Aug 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

UNAMITY

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, alzheimer's, anxiety disord Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, Dementia and Parkinson's disease, neurological disorders namely, Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Diagnostic reagents for medical diagnostic use; Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.


Classification kind code

10

Mark Details


Serial Number

1771260

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 51
on 25th May 2018
Allowance Notice Sent
Submitted for opposition 42
on 7th Feb 2018
Advertised
Submitted for opposition 26
on 18th Jan 2018
Approved
Submitted for opposition 27
on 29th Nov 2017
Approval Notice Sent
Submitted for opposition 15
on 25th Jan 2017
Correspondence Created
Submitted for opposition 22
on 9th Sept 2016
Search Recorded
Submitted for opposition 20
on 9th Sept 2016
Examiner's First Report
Submitted for opposition 31
on 11th Mar 2016
Formalized
Submitted for opposition 1
on 9th Mar 2016
Created
Submitted for opposition 30
on 8th Mar 2016
Filed